Synthaverse SA
F:6NQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Synthaverse SA
F:6NQ
|
PL |
|
Sipai Health Technology Co, Ltd
F:AX1
|
CN |
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6NQ's stock price target?
Not Available
6NQ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Synthaverse SA?
Projected CAGR
44%
Over the last 12 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 1 year is 44%.
What is the Gross Profit forecast for Synthaverse SA?
Projected CAGR
-18%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is -18%.
What is the Operating Income forecast for Synthaverse SA?
Projected CAGR
183%
The compound annual growth rate for Operating Income over the next 1 year is 183%.
What is the Pre-Tax Income forecast for Synthaverse SA?
Projected CAGR
30%
The compound annual growth rate for Pre-Tax Income over the next 1 year is 30%.
What is the Net Income forecast for Synthaverse SA?
Projected CAGR
20%
The compound annual growth rate for Net Income over the next 1 year is 20%.
